Circle posted a photo of DJ Khaled wearing a Chelsea FC jersey branded with USDC, sparking backlash due to Khaled's 2018 SEC settlement over an undisclosed crypto promotion. Although Circle did not announce a formal endorsement or sponsorship, many perceived the post as one, leading to criticism. The incident highlights risks in celebrity crypto associations, especially given USDC's role as a major stablecoin with a $74 billion market cap. Circle's Chelsea sponsorship means anyone wearing the jersey can appear as an unofficial USDC promoter, underscoring the need for careful public relations and due diligence in crypto marketing.
The Circle and DJ Khaled USDC collaboration drew attention alongside Pluang's crypto market snapshot. For readers following the crypto sector, here is Pluang's market snapshot as of Oct 07, 2026 04:41 WIB: out of 50 major cryptocurrencies, 9 rose and 40 fell today. Notable movers include CAKE (PancakeSwap) at Rp42.953 with a 1-day change of -4.23% and a typical hold time of 75 days, EGLD (MultiversX) at Rp79.645 down 4.07%, and SAND (The Sandbox) at Rp1.184 down 4.02%.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
U.S. spot Solana ETFs experienced $3.7 million in net outflows on October 6, marking the second consecutive day of withdrawals. The Grayscale Solana Trust was the main contributor to this decline, while six other funds showed no net flow. Although th...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
